Brief

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched its 2024/25 Business Plan, focusing on facilitating access to innovative new products while ensuring high-quality regulatory services. On 07/10/2024, the MHRA issued an update regarding "MHRA launches 2024/25 business plan with focus on enabling access to groundbreaking new technology while optimising delivery for all who need our services." The agency's core mission remains unchanged – to protect and promote public health by ensuring healthcare products work and are acceptably safe.

Hello!

To view this content, please sign up or log in – it’s free and easy! Stay ahead with curated regulatory insights designed for professionals like you.

Go to Home Page

Highlights content goes here...

Hello!

To view this content, please sign up or log in – it’s free and easy! Stay ahead with curated regulatory insights designed for professionals like you.

Go to Home Page

Medicines and Healthcare products Regulatory Agency (MHRA)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies